- Home
- CDTX vs CMPR Comparison
CDTX vs CMPR Comparison
Compare CDTX & CMPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- CMPR
- Stock Information
- Founded
- CDTX 2012
- CMPR 1994
- Country
- CDTX United States
- CMPR Ireland
- Employees
- CDTX N/A
- CMPR N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- CMPR Publishing
- Sector
- CDTX Health Care
- CMPR Consumer Discretionary
- Exchange
- CDTX Nasdaq
- CMPR Nasdaq
- Market Cap
- CDTX 1.4B
- CMPR 1.2B
- IPO Year
- CDTX 2015
- CMPR N/A
- Fundamental
- Price
- CDTX $66.37
- CMPR $62.66
- Analyst Decision
- CDTX Strong Buy
- CMPR Strong Buy
- Analyst Count
- CDTX 11
- CMPR 2
- Target Price
- CDTX $57.00
- CMPR $72.00
- AVG Volume (30 Days)
- CDTX 427.5K
- CMPR 275.4K
- Earning Date
- CDTX 08-07-2025
- CMPR 07-29-2025
- Dividend Yield
- CDTX N/A
- CMPR N/A
- EPS Growth
- CDTX N/A
- CMPR N/A
- EPS
- CDTX N/A
- CMPR 0.58
- Revenue
- CDTX N/A
- CMPR $3,403,079,000.00
- Revenue This Year
- CDTX N/A
- CMPR $4.43
- Revenue Next Year
- CDTX N/A
- CMPR $3.29
- P/E Ratio
- CDTX N/A
- CMPR $108.60
- Revenue Growth
- CDTX N/A
- CMPR 3.38
- 52 Week Low
- CDTX $10.14
- CMPR $35.21
- 52 Week High
- CDTX $69.36
- CMPR $102.22
- Technical
- Relative Strength Index (RSI)
- CDTX 65.51
- CMPR 71.54
- Support Level
- CDTX $59.80
- CMPR $58.72
- Resistance Level
- CDTX $69.36
- CMPR $61.13
- Average True Range (ATR)
- CDTX 3.83
- CMPR 2.28
- MACD
- CDTX -0.38
- CMPR 0.20
- Stochastic Oscillator
- CDTX 76.70
- CMPR 89.04
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About CMPR Cimpress plc (Ireland)
Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.